82 FR 10021 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 26 (February 9, 2017)

Page Range		10021-10022
FR Document		2017-02621

Federal Register, Volume 82 Issue 26 (Thursday, February 9, 2017)

[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Pages 10021-10022]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-02621]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions

[[Page 10022]]

could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications/contract proposals, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Questions in Cancer System Biology.
    Date: March 2, 2017.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E908, Rockville, MD 20850.
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Tools for Monitoring RNA.
    Date: March 14, 2017.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Co-Clinical Imaging.
    Date: March 30, 2017.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20892-9750, 240-276-6373, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Collaborative Consortia for the Study of HIV-Associated 
Cancers (U54) RFA-CA-16-018.
    Date: April 5-6, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Rockville, MD 20892-9750, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Center Support Grant.
    Date: April 7, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6459, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 3, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02621 Filed 2-8-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices 10021

Contact Person: David R. Jollie, Ph.D., Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
Scientific Review Officer, Center for applications. HUMAN SERVICES
Scientific Review, National Institutes of Place: Residence Inn Bethesda, 7335
Health, 6701 Rockledge Drive, Room 4166, Wisconsin Avenue, Bethesda, MD 20814. National Institutes of Health
MSC 7806, Bethesda, MD 20892, (301) 437– Contact Person: Vilen A. Movsesyan,
7927, jollieda@csr.nih.gov. Ph.D., Scientific Review Officer, Center for National Institute on Minority Health
Name of Committee: Center for Scientific Scientific Review, National Institutes of and Health Disparities; Notice of
Review Special Emphasis Panel; Topics in Health, 6701 Rockledge Drive, Room 4040M, Closed Meeting
Bacterial Pathogenesis. MSC 7806, Bethesda, MD 20892, 301–402–
Date: March 9, 2017. 7278, movsesyanv@csr.nih.gov. Pursuant to section 10(d) of the
Time: 8:00 a.m. to 6:00 p.m. Federal Advisory Committee Act, as
Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member amended (5 U.S.C. App.), notice is
applications.
Conflict: Larynx and Voice Disorders. hereby given of the following meeting.
Place: Hotel Solamar, 435 6th Avenue, San
Diego, CA 92101. Date: March 9, 2017. The meeting will be closed to the
Contact Person: Richard G. Kostriken, Time: 1:00 p.m. to 2:00 p.m. public in accordance with the
Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant provisions set forth in sections
Scientific Review, National Institutes of applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Health, 6701 Rockledge Drive, Room 3192, Place: National Institutes of Health, 6701 as amended. The grant applications and
MSC 7808, Bethesda, MD 20892, 240–519– Rockledge Drive, Bethesda, MD 20892, the discussions could disclose
7808, kostrikr@csr.nih.gov. (Telephone Conference Call). confidential trade secrets or commercial
Name of Committee: Center for Scientific Contact Person: Unja Hayes, Ph.D., property such as patentable materials,
Review Special Emphasis Panel; Scientific Review Officer, National Institutes and personal information concerning
Fellowships: Biophysical, Physiological, of Health, Center for Scientific Review, 6701
individuals associated with the grant
Pharmacological and Bioengineering Rockledge Drive, Bethesda, MD 20892, 301–
applications, the disclosure of which
Neuroscience. 827–6830, unja.hayes@nih.gov.
Date: March 9–10, 2017.
would constitute a clearly unwarranted
Name of Committee: Center for Scientific invasion of personal privacy.
Time: 8:00 a.m. to 5:00 p.m. Review Special Emphasis Panel; PAR 16–
Agenda: To review and evaluate grant 333: Metabolic Contributions to the Name of Committee: National Institute on
applications. Neurocognitive Complications of Diabetes: Minority Health and Health Disparities
Place: The Fairmont Washington, DC, 2401 Ancillary Studies (R01). Special Emphasis Panel; Internet Assisted
M Street NW., Washington, DC 20037. Date: March 9, 2017. Meeting, ZMD1 XLN M1.
Contact Person: Paula Elyse Schauwecker, Time: 1:00 p.m. to 3:00 p.m. Date: March 13, 2017.
Ph.D., Scientific Review Officer, National Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
Institutes of Health, Center for Scientific Agenda: To review and evaluate grant
applications.
Review, 6701 Rockledge Drive, Room 5211, applications.
Place: National Institutes of Health, 6701
Bethesda, MD 20892, schauweckerpe@ Place: National Institutes of Health, Two
csr.nih.gov. Rockledge Drive, Bethesda, MD 20892,
Democracy Plaza, 6707 Democracy
Name of Committee: Center for Scientific (Telephone Conference Call).
Boulevard, Bethesda, MD 20892 (Virtual
Review Special Emphasis Panel; Small Contact Person: Hui Chen, MD, Scientific
meeting).
Business: Biomedical Sensing, Measurement Review Officer, Center for Scientific Review, Contact Person: Xinli Nan, Ph.D., Scientific
and Instrument. National Institutes of Health, 6701 Rockledge Review Officer, National Institute on
Date: March 9, 2017. Drive, Bethesda, MD 20892, 301–435–1044, Minority Health and Health Disparities,
Time: 8:00 a.m. to 6:00 p.m. chenhui@csr.nih.gov. National Institutes of Health, Scientific
Agenda: To review and evaluate grant Name of Committee: Center for Scientific Review Branch, OERA, 6707 Democracy
applications. Review Special Emphasis Panel; Blvd., Suite 800, Bethesda, MD 20892, (301)
Place: Hotel Solamar, 435 6th Avenue, San Fellowships: Endocrinology, Metabolism, 594–7784, Xinli.Nan@nih.gov.
Diego, CA 92101. Nutrition, and Reproductive Science. Dated: February 2, 2017.
Contact Person: Inna Gorshkova, Ph.D., Date: March 10, 2017.
Scientific Review Officer, Center for Time: 11:00 a.m. to 5:00 p.m. David Clary,
Scientific Review, National Institutes of Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory
Health, 6701 Rockledge Drive, Bethesda, MD applications. Committee Policy.
20892, 301–435–1784, gorshkoi@csr.nih.gov. Place: National Institutes of Health, 6701 [FR Doc. 2017–02614 Filed 2–8–17; 8:45 am]
Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892, BILLING CODE 4140–01–P
Review Special Emphasis Panel; Small (Virtual Meeting).
Business: Aging and Development, Auditory, Contact Person: Elaine Sierra-Rivera, Ph.D.,
Vision and Low Vision Technologies. Scientific Review Officer, EMNR IRG, Center DEPARTMENT OF HEALTH AND
Date: March 9–10, 2017. for Scientific Review, National Institutes of HUMAN SERVICES
Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 6182,
Agenda: To review and evaluate grant MSC 7892, Bethesda, MD 20892, 301 435– National Institutes of Health
applications. 2514, riverase@csr.nih.gov.
Place: The Westgate Hotel, 1055 Second
(Catalogue of Federal Domestic Assistance National Cancer Institute; Notice of
Avenue, San Diego, CA 92101.
Contact Person: Paek-Gyu Lee, Ph.D., Program Nos. 93.306, Comparative Medicine; Closed Meetings
Scientific Review Officer, Center for 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844, Pursuant to section 10(d) of the
Scientific Review, National Institutes of Federal Advisory Committee Act, as
Health, 6701 Rockledge Drive, Room 4201, 93.846–93.878, 93.892, 93.893, National
sradovich on DSK3GMQ082PROD with NOTICES

MSC 7812, Bethesda, MD 20892, (301) 613– Institutes of Health, HHS) amended (5 U.S.C. App.), notice is
2064, leepg@csr.nih.gov. hereby given of the following meetings.
Dated: February 3, 2017. The meetings will be closed to the
Name of Committee: Center for Scientific Anna Snouffer,
Review Special Emphasis Panel; public in accordance with the
Deputy Director, Office of Federal Advisory provisions set forth in sections
Fellowships: Brain Disorders and Related
Committee Policy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Neurosciences.
Date: March 9–10, 2017. [FR Doc. 2017–02618 Filed 2–8–17; 8:45 am] as amended. The grant applications/
Time: 8:00 a.m. to 5:00 p.m. BILLING CODE 4140–01–P contract proposals and the discussions

VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

10022 Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices

could disclose confidential trade secrets Training Review Branch, Division of Fishers Lane, Rockville, MD, 20852; tel.
or commercial property such as Extramural Activities, National Cancer 301–496–2644. A signed Confidential
patentable material, and personal Institute, NIH, 9609 Medical Center Drive, Disclosure Agreement will be required
Room 7W234, Rockville, MD 20892–9750,
information concerning individuals to receive copies of unpublished patent
240–276–6368, stoicaa2@mail.nih.gov.
associated with the grant applications/ applications.
Name of Committee: National Cancer
contract proposals, the disclosure of Institute Special Emphasis Panel; Cancer SUPPLEMENTARY INFORMATION:
which would constitute a clearly Center Support Grant. Technology description follows.
unwarranted invasion of personal Date: April 7, 2017.
privacy. Time: 1:00 p.m. to 3:00 p.m.
Small Molecule Imaging of Fungi by
Agenda: To review and evaluate grant Positron Emission Tomography
Name of Committee: National Cancer Scanning
Institute Special Emphasis Panel; Questions applications.
in Cancer System Biology. Place: National Cancer Institute Shady Description of Technology
Date: March 2, 2017. Grove, 9609 Medical Center Drive, Room
Time: 8:00 a.m. to 4:00 p.m. 7W030, Rockville, MD 20850 (Telephone This technology relates to the field of
Agenda: To review and evaluate grant Conference Call). radioactive, isotopically-labeled
applications. Contact Person: Caterina Bianco, MD, calcofluor derivatives and uses of such
Place: National Cancer Institute Shady Ph.D., Scientific Review Officer, Research compounds to detect a broad spectrum
Grove, 9609 Medical Center Drive, Room Programs Review Branch, Division of
of filamentous fungi including
2E908, Rockville, MD 20850. Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive, pathogenic species such as Aspergillus
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and Room 7W110, Bethesda, MD 20892–9750, and Mucorales, by diagnostic imaging
Training Review Branch, Division of 240–276–6459, biancoc@mail.nih.gov. methods such as positron emission
Extramural Activities, National Cancer (Catalogue of Federal Domestic Assistance tomography (PET) scanning.
Institute, NIH, 9609 Medical Center Drive, Program Nos. 93.392, Cancer Construction; Aspergillosis and other filamentous
Room 7W234, Bethesda, MD 20892–9750, 93.393, Cancer Cause and Prevention fungal infections are increasingly
240–276–6368, stoicaa2@mail.nih.gov. Research; 93.394, Cancer Detection and common fungal lung infection with high
Name of Committee: National Cancer Diagnosis Research; 93.395, Cancer mortality rates (over 50%) in immune
Institute Special Emphasis Panel; Tools for Treatment Research; 93.396, Cancer Biology compromised patients, such as those
Monitoring RNA. Research; 93.397, Cancer Centers Support;
receiving chemotherapy, stem cell/organ
Date: March 14, 2017. 93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health, transplantation, or HIV patients. One-
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant HHS) year survival of the infected patients
applications. ranges from 59% (organ transplant
Dated: February 3, 2017.
Place: National Cancer Institute Shady recipients) to as low as 25% (stem cell
Grove, 9609 Medical Center Drive, Room Melanie J. Pantoja, transplant recipients). Delayed
4W030, Rockville, MD 20850 (Telephone Program Analyst, Office of Federal Advisory diagnosis and therapy are likely to lead
Conference Call). Committee Policy. to poor outcomes and death. This
Contact Person: Jeffrey E. DeClue, Ph.D., [FR Doc. 2017–02621 Filed 2–8–17; 8:45 am] disease is often first detected as nodules
Scientific Review Officer, Research
Technology and Contract Review Branch,
BILLING CODE 4140–01–P on CT scans. A diagnosis is typically
Division of Extramural Activities, National made following invasive lung
Cancer Institute, NIH, 9609 Medical Center bronchoscopy or biopsy. However, as
Drive, Room 7W238, Bethesda, MD 20892– DEPARTMENT OF HEALTH AND these patients are
9750, 240–276–6371, decluej@nih.gov. HUMAN SERVICES immunocompromised, these invasive
Name of Committee: National Cancer procedures may themselves lead to
Institute Special Emphasis Panel; Co-Clinical National Institutes of Health
significant complications and
Imaging. infections. Therefore, to enable timely
Date: March 30, 2017. Government-Owned Inventions;
Availability for Licensing treatment and minimize complications,
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract there is a critical need for non-invasive
AGENCY: National Institutes of Health, means to detect and diagnose fungal
proposals.
Place: National Cancer Institute Shady HHS. infections.
Grove, 9609 Medical Center Drive, Room ACTION: Notice. The calcofluor derivatives disclosed
7W030, Rockville, MD 20850 (Telephone in the patent application may be
Conference Call). SUMMARY: The invention listed below is utilized as imaging agents specific for
Contact Person: Kenneth L. Bielat, Ph.D., owned by an agency of the U.S. fungal infections and could potentially
Scientific Review Officer, Research Government and is available for become a standard, non-invasive
Technology and Contract Review Branch, licensing to achieve expeditious
Division of Extramural Activities, National procedure in the work-up of
commercialization of results of immunocompromised patients with
Cancer Institute, NIH, 9609 Medical Center federally-funded research and
Drive, Room 7W244, Rockville, MD 20892– lung infections.
9750, 240–276–6373, bielatk@mail.nih.gov. development. Foreign patent This technology is available for
Name of Committee: National Cancer
applications are filed on selected licensing for commercial development
Institute Special Emphasis Panel; inventions to extend market coverage in accordance with 35 U.S.C. 209 and 37
Collaborative Consortia for the Study of HIV- for companies and may also be available CFR part 404, as well as for further
Associated Cancers (U54) RFA–CA–16–018. for licensing. development and evaluation under a
Date: April 5–6, 2017. FOR FURTHER INFORMATION CONTACT:
sradovich on DSK3GMQ082PROD with NOTICES

research collaboration.
Time: 8:00 a.m. to 5:00 p.m. Licensing information and copies of the
Agenda: To review and evaluate grant patent applications listed below may be Potential Commercial Applications
applications.
Place: Bethesda North Marriott Hotel &
obtained by communicating with the • Diagnostics of Aspergillosis and
Conference Center, 5701 Marinelli Road, indicated licensing contact at the other filamentous fungal infections.
North Bethesda, MD 20852. Technology Transfer and Intellectual
Property Office, National Institute of Competitive Advantages
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and Allergy and Infectious Diseases, 5601 • Non-invasive.

VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

Document Created: 2017-02-09 01:02:47
Document Modified: 2017-02-09 01:02:47

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 2, 2017.
FR Citation		82 FR 10021

82 FR 10021 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 26 (February 9, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health